# Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis

> **NCT01314495** · PHASE2 · WITHDRAWN · sponsor: **Julian M. Mackay-Wiggan**

## Conditions studied

- Alopecia Totalis/Universalis

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Inactive infusion

## Key facts

- **NCT ID:** NCT01314495
- **Lead sponsor:** Julian M. Mackay-Wiggan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Halt in funding
- **Last updated:** 2012-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314495, "Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01314495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*